Verve Therapeutics VERV 深 沪
等待开盘 02-05 09:30:00 美东时间
11.13
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 11.13
- 总市值 9.94亿
- 52周最高 11.405
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.8647
- 委 比 0.00%
- 总股本 8931.22万
- 历史最高 78.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.8647
- 每 手 1
- 风险率 2.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多超30亿美元！这家MNC持续押注尚无药物的听力损伤赛道
（来源：动脉新医药） 1月28日，Seamless Therapeutics与礼来签订全球战略研究合作和许可协议。根据协议条款，Seamless将利用其专有重组...
01-29 18:34
Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless
Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless By Mariam Sunny and Bhanvi Satija Jan 28 (Reuters) - U.S. drugmaker Eli Lilly LLY.N signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup said on Wednesday, to develop and c
01-28 20:00
Verve Therapeutics Announces Merger and Nasdaq Delisting
Verve Therapeutics ( ($VERV) ) just unveiled an update. Verve Therapeutics has ...
2025-07-26 04:51
Eli Lilly And Verve Therapeutics Announces That The Tender Offer For All Outstanding Verve Shares, Priced At $10.50 Per Share In Cash Plus A Potential Additional $3.00 Via A Non-Tradable Contingent Value Right, Officially Expired At 12:01 A.M. Et On July 24, 2025. The Offer Was Not Extended.
Eli Lilly and Company (NYSE:LLY) and Verve Therapeutics, Inc. (NASDAQ:VERV) today announced that the tender offer to purchase all of the issued and outstanding shares ("Shares") of Verve's common stock in exchange for
2025-07-24 20:05
Lilly and Verve announce expiration of Verve tender offer
INDIANAPOLIS, July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (NASDAQ: VERV) today announced that the tender offer to purchase all of the issued ...
2025-07-24 20:00
Verve Therapeutics Announces Retention Bonus Program for Executives
Verve Therapeutics ( ($VERV) ) has shared an announcement. Verve Therapeutics a...
2025-07-15 18:45
Prime Medicine soars as Jones sees it as an acquisition target
Prime Therapeutics (NASDAQ:PRME) skyrocketed ~35% Monday after JonesTrading issued a bullish report on the company due to increased interest in gene editing in the wake of Eli Lilly's (NYSE:LLY) deal ...
2025-07-08 00:33
美股大行评级 | 潜在涨幅205.56%！康托·菲茨杰拉德上调HIVE Digital Technologies目标价至5.5美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1145638202455883776.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 康托·菲茨杰拉德：维持HIVE Digital Technologies(HIVE)"超配"评级，目标价从5美元升至5.5美元</p> <p>• BTIG：维持Theravance Biopharma(TBPH)"买入"评
2025-06-28 08:37
